Traders Lens

Chinese data center stock $GDS is leading the Prism MarketView AI Datacenter and Infrastructure index today. News came out this morning that they are considering…

$LIPO is leading the Prism MarketView Pharmaceuticals index after gaining FDA approval for an Expanded Access Program for LP-310, an oral rinse for treating oral…

$BDRX is leading the Prism MarketView Pharmaceuticals index. The company released this morning that it has received US FDA Fast Track Designation for eRapa in…

$BBAI is up 100% this week and leading the Prism MarketView NextGen Tech index

Shares of $NKLA are sliding today and its currently the biggest laggard in the Prism MarketView EV index as reports of it nearing bankruptcy are…

$SRTS is the biggest laggard in the Prism MarketView MedDevices index. The company released its Q4 results after yesterdays close.

$EQ is leading the Prism MarketView Biotech index. Equillium announced positive data from its Phase 2 Study evaluating Itolizumab in Patients with moderate to severe…

$CPIX surged yesterday and is continuing its move up today and leading the Prism MarketView Pharmaceuticals index. Yesterday they announced positive top-line results from its…

$QNTM is the leader of the Prism MarketView Psychedelics index announcing successful results of its clinical trial for unbuzzd™, which significantly accelerates alcohol metabolism and…

$ACHL is leading the Prism MarketView Biotech index, the company announced today a proposal for a members’ voluntary liquidation to return capital to shareholders following a…

$ANVS is the biggest laggard in the Prism MarketView Global Health index today after the company announced a $21 million offering of stock and warrants.

$GHRS shares are surging today and leading the Prism MarketView Psychedelics index after they released results from their Phase 2b trial for GH001, aimed at…